Cargando…
Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes
PURPOSE: The association between serum osteocalcin (OCN) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few studies have explored their relationship in type 2 diabetes mellitus (T2DM) patients so far. The present study aimed to investigate t...
Autores principales: | Wang, Yu-Jie, Jin, Chun-Hua, Ke, Jiang-Feng, Wang, Jun-Wei, Ma, Yi-Lin, Lu, Jun-Xi, Li, Mei-Fang, Li, Lian-Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719286/ https://www.ncbi.nlm.nih.gov/pubmed/36471670 http://dx.doi.org/10.2147/DMSO.S389794 |
Ejemplares similares
-
Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
por: Wang, Jun-Wei, et al.
Publicado: (2022) -
GA/HbA1c ratio is a simple and practical indicator to evaluate the risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: an observational study
por: Wang, Jun-Wei, et al.
Publicado: (2022) -
Relationship between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Adult Males, South China
por: Liu, Jun-Jie, et al.
Publicado: (2013) -
Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021) -
Serum osteocalcin levels in overweight children
por: Oh, Seok Bin, et al.
Publicado: (2019)